肝損傷(Hepatic Injury):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Hepatic Injury Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatic Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Hepatic Injury to Gastrointestinal Clinical Trials 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Hepatic Injury to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Hepatic Injury 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hepatic Injury Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Takeda Pharmaceutical Company Limited 26
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 26
Pfizer Inc. 27
Clinical Trial Overview of Pfizer Inc. 27
Ocera Therapeutics, Inc. 28
Clinical Trial Overview of Ocera Therapeutics, Inc. 28
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
McNEIL-PPC, Inc. 30
Clinical Trial Overview of McNEIL-PPC, Inc. 30
Jubilant Life Sciences Limited 31
Clinical Trial Overview of Jubilant Life Sciences Limited 31
Indivior PLC 32
Clinical Trial Overview of Indivior PLC 32
Ikaria Holdings, Inc. 33
Clinical Trial Overview of Ikaria Holdings, Inc. 33
Golden Biotechnology Corp. 34
Clinical Trial Overview of Golden Biotechnology Corp. 34
Cumberland Pharmaceuticals, Inc. 35
Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 35
Clinical Trial Overview of Top Institutes / Government 36
Children’s Medical Center 36
Clinical Trial Overview of Children’s Medical Center 36
Chonbuk National University Hospital 37
Clinical Trial Overview of Chonbuk National University Hospital 37
Denver Health and Hospital Authority 38
Clinical Trial Overview of Denver Health and Hospital Authority 38
Hillerod Hospital 39
Clinical Trial Overview of Hillerod Hospital 39
Seoul National University Hospital 40
Clinical Trial Overview of Seoul National University Hospital 40
The First Affiliated Hospital of Sun Yat-sen University 41
Clinical Trial Overview of The First Affiliated Hospital of Sun Yat-sen University 41
Thomas Jefferson University 42
Clinical Trial Overview of Thomas Jefferson University 42
University of Alabama at Birmingham 43
Clinical Trial Overview of University of Alabama at Birmingham 43
University of Texas Southwestern Medical Center at Dallas 44
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 44
Five Key Clinical Profiles 45
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67


【レポート販売概要】

■ タイトル:肝損傷(Hepatic Injury):世界の治験レビュー(2015年上半期版)
■ 英文:Hepatic Injury Global Clinical Trials Review, H1, 2015
■ 発行日:2015年4月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2667CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。